Kenvue stock gains after court victory in case over Tylenol purported links to autism

skhoward

Update 9:05pm: Adds Kenvue comment.

Kenvue (NYSE:KVUE) rose 5% in after hours trading after a court ruled in it favor in a class action lawsuit alleging prenatal exposure to Tylenol may contribute to autism or attention-deficit hyperactivity disorder.

Kenvue’s motion to to

autismCaseCourtgainsKenvueLinkspurportedstockTylenolVictory
Comments (0)
Add Comment